576 related articles for article (PubMed ID: 33128875)
21. Platelet functions and activities as potential hematologic parameters related to Coronavirus Disease 2019 (Covid-19).
Salamanna F; Maglio M; Landini MP; Fini M
Platelets; 2020 Jul; 31(5):627-632. PubMed ID: 32397915
[TBL] [Abstract][Full Text] [Related]
22. Atypical lymphocytes in peripheral blood of patients with COVID-19.
Weinberg SE; Behdad A; Ji P
Br J Haematol; 2020 Jul; 190(1):36-39. PubMed ID: 32420613
[No Abstract] [Full Text] [Related]
23. Neutrophil-to-Lymphocyte ratio as a potential biomarker for disease severity in COVID-19 patients.
Haghjooy Javanmard S; Vaseghi G; Manteghinejad A; Nasirian M
J Glob Antimicrob Resist; 2020 Sep; 22():862-863. PubMed ID: 32810639
[TBL] [Abstract][Full Text] [Related]
24. Fungal antigenemia in patients with severe Coronavirus disease 2019 (COVID-19): The facts and challenges.
Lei Y; Song Y; Shu Y; Zhao Y; Huo X; Wang H; Zeng Y; Yu X; Li X; Ye G; Fang B; Han S; Li R; Liu L
J Microbiol Immunol Infect; 2020 Aug; 53(4):657-659. PubMed ID: 32482367
[No Abstract] [Full Text] [Related]
25. Plasma IP-10 and MCP-3 levels are highly associated with disease severity and predict the progression of COVID-19.
Yang Y; Shen C; Li J; Yuan J; Wei J; Huang F; Wang F; Li G; Li Y; Xing L; Peng L; Yang M; Cao M; Zheng H; Wu W; Zou R; Li D; Xu Z; Wang H; Zhang M; Zhang Z; Gao GF; Jiang C; Liu L; Liu Y
J Allergy Clin Immunol; 2020 Jul; 146(1):119-127.e4. PubMed ID: 32360286
[TBL] [Abstract][Full Text] [Related]
26. Erythrocyte, Platelet, Serum Ferritin, and P-Selectin Pathophysiology Implicated in Severe Hypercoagulation and Vascular Complications in COVID-19.
Venter C; Bezuidenhout JA; Laubscher GJ; Lourens PJ; Steenkamp J; Kell DB; Pretorius E
Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33153161
[TBL] [Abstract][Full Text] [Related]
27. Serum Proteomics in COVID-19 Patients: Altered Coagulation and Complement Status as a Function of IL-6 Level.
D'Alessandro A; Thomas T; Dzieciatkowska M; Hill RC; Francis RO; Hudson KE; Zimring JC; Hod EA; Spitalnik SL; Hansen KC
J Proteome Res; 2020 Nov; 19(11):4417-4427. PubMed ID: 32786691
[TBL] [Abstract][Full Text] [Related]
28. Disease severity dictates SARS-CoV-2-specific neutralizing antibody responses in COVID-19.
Chen X; Pan Z; Yue S; Yu F; Zhang J; Yang Y; Li R; Liu B; Yang X; Gao L; Li Z; Lin Y; Huang Q; Xu L; Tang J; Hu L; Zhao J; Liu P; Zhang G; Chen Y; Deng K; Ye L
Signal Transduct Target Ther; 2020 Sep; 5(1):180. PubMed ID: 32879307
[TBL] [Abstract][Full Text] [Related]
29. Helping doctors hasten COVID-19 treatment: Towards a rescue framework for the transfusion of best convalescent plasma to the most critical patients based on biological requirements via ml and novel MCDM methods.
Albahri OS; Al-Obaidi JR; Zaidan AA; Albahri AS; Zaidan BB; Salih MM; Qays A; Dawood KA; Mohammed RT; Abdulkareem KH; Aleesa AM; Alamoodi AH; Chyad MA; Zulkifli CZ
Comput Methods Programs Biomed; 2020 Nov; 196():105617. PubMed ID: 32593060
[TBL] [Abstract][Full Text] [Related]
30. Integrative Modeling of Quantitative Plasma Lipoprotein, Metabolic, and Amino Acid Data Reveals a Multiorgan Pathological Signature of SARS-CoV-2 Infection.
Kimhofer T; Lodge S; Whiley L; Gray N; Loo RL; Lawler NG; Nitschke P; Bong SH; Morrison DL; Begum S; Richards T; Yeap BB; Smith C; Smith KGC; Holmes E; Nicholson JK
J Proteome Res; 2020 Nov; 19(11):4442-4454. PubMed ID: 32806897
[TBL] [Abstract][Full Text] [Related]
31. Erythrocyte sedimentation rate is associated with severe coronavirus disease 2019 (COVID-19): a pooled analysis.
Lapić I; Rogić D; Plebani M
Clin Chem Lab Med; 2020 Jun; 58(7):1146-1148. PubMed ID: 32386190
[No Abstract] [Full Text] [Related]
32. Feasibility of a pilot program for COVID-19 convalescent plasma collection in Wuhan, China.
Li L; Yang R; Wang J; Lv Q; Ren M; Zhao L; Chen H; Xu H; Xie S; Xie J; Lin H; Li W; Fang P; Gong L; Wang L; Wu Y; Liu Z
Transfusion; 2020 Aug; 60(8):1773-1777. PubMed ID: 32491199
[TBL] [Abstract][Full Text] [Related]
33. Platelet gene expression and function in patients with COVID-19.
Manne BK; Denorme F; Middleton EA; Portier I; Rowley JW; Stubben C; Petrey AC; Tolley ND; Guo L; Cody M; Weyrich AS; Yost CC; Rondina MT; Campbell RA
Blood; 2020 Sep; 136(11):1317-1329. PubMed ID: 32573711
[TBL] [Abstract][Full Text] [Related]
34. Researchers Home in on COVID-19 Severity Biomarkers.
Abbasi J
JAMA; 2020 Jul; 324(2):128. PubMed ID: 32662846
[No Abstract] [Full Text] [Related]
35. Blood clots and TAM receptor signalling in COVID-19 pathogenesis.
Lemke G; Silverman GJ
Nat Rev Immunol; 2020 Jul; 20(7):395-396. PubMed ID: 32488201
[TBL] [Abstract][Full Text] [Related]
36. Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): a meta-analysis.
Henry BM; de Oliveira MHS; Benoit S; Plebani M; Lippi G
Clin Chem Lab Med; 2020 Jun; 58(7):1021-1028. PubMed ID: 32286245
[TBL] [Abstract][Full Text] [Related]
37. Platelet activation and platelet-monocyte aggregate formation trigger tissue factor expression in patients with severe COVID-19.
Hottz ED; Azevedo-Quintanilha IG; Palhinha L; Teixeira L; Barreto EA; Pão CRR; Righy C; Franco S; Souza TML; Kurtz P; Bozza FA; Bozza PT
Blood; 2020 Sep; 136(11):1330-1341. PubMed ID: 32678428
[TBL] [Abstract][Full Text] [Related]
38. Re The source of elevated plasma D-dimer levels in COVID-19 infection.
Hunt BJ; Levi M
Br J Haematol; 2020 Aug; 190(3):e133-e134. PubMed ID: 32484901
[No Abstract] [Full Text] [Related]
39. Voice from China: nomenclature of the novel coronavirus and related diseases.
Chin Med J (Engl); 2020 May; 133(9):1012-1014. PubMed ID: 32118646
[No Abstract] [Full Text] [Related]
40. C-reactive protein correlates with computed tomographic findings and predicts severe COVID-19 early.
Tan C; Huang Y; Shi F; Tan K; Ma Q; Chen Y; Jiang X; Li X
J Med Virol; 2020 Jul; 92(7):856-862. PubMed ID: 32281668
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
